All In Biotech

Free tool

FAERS Monitor: Mvasi

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761028 or its brand name (Mvasi, Bevacizumab-Awwb). Reports on generic versions are filed under their own applications.

Reports

4,692

Serious

1,397

30% of reports

Hospitalization

409

Death reported

144

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use502
  • product storage error437
  • circumstance or information capable of leading to medication error346
  • hypertension215
  • disease progression195
  • blood pressure increased181
  • product dose omission issue158
  • adverse event145
  • fatigue130
  • platelet count decreased130
  • nausea108
  • diarrhoea99
  • intercepted product administration error98
  • malaise96
  • ill-defined disorder92

Reports by year received

View as table
YearReports
20131
20161
20171
201928
2020299
2021805
2022846
20231,008
2024797
2025612
2026294

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,467 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
intercepted product administration errorSignal9858.047.65,368
circumstance or information capable of leading to medication errorSignal34646.441.915,187
product storage errorSignal43722.520.68,942
disease progressionSignal1957.46.41,077
adverse eventSignal1457.16.0751
ill-defined disorderSignal926.85.6450
platelet count decreasedSignal1305.54.6473
blood pressure increasedSignal1815.34.6633
hypertensionSignal2154.64.0598
off label useSignal5022.62.4501
product dose omission issueSignal1582.42.1131
malaise961.00.80
fatigue1300.70.611
diarrhoea990.70.614
nausea1080.60.527

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.